"A Lung-RADS screening classification exists for the purpose of standardising follow up and management."
"RANZCR lung cancer screening structured clinical radiology report"
"slightly healthier study cohort than U.S. population overall"
"positive if at least one noncalcified nodule >= 4 mm"
"The National Lung Cancer Screening Program (Australia)"
Expected headings
"Screening guidelines"
"Advantages to screening"
"Disadvantages to screening"
"Evidence"
"National lung screening trial"
"Results"
"As with any screening program, the population-level benefits must be greater than the risks. There is increasing evidence that low-dose lung cancer screening benefits outweigh the risks at this time for selected patient groups. There is continued debate over the cost-effectiveness of screening, but it may be cost-effective if limited to the study population or selected subgroups of the study population."
"As with any screening program, the population-level benefits must be greater than the risks. There is increasing evidence that low-dose lung cancer screening benefits outweigh the risks at this time for selected patient groups. There is continued debate over the cost-effectiveness of screening, but it may be cost-effective if limited to the study population or selected subgroups of the study population."